Becton Dickinson sees FY24 adjusted EPS $12.70-$13.00, consensus $13.49

Sees FY24 revenue $20.1B-$20.3B, consensus $20.32B. The company said, “Organic revenue growth is expected to be 5.25% to 6.25% including a headwind of over 25 basis points from the expected decline in COVID-only diagnostic testing. Total currency-neutral revenue growth is expected to be 4.5% to 5.5%. This reflects a negative impact of approximately 75 basis points from the impact of the Surgical Instrumentation platform divestiture. Based on current rates, foreign exchange represents a reduction of approximately 75 basis points to total company revenue growth.” Consensus figures from Zack’s.